Published: May 31, 2018

Introduction {#sec1}
============

The activity-regulated protein Arc/Arg3.1 (Arc) is essential for spatial memory acquisition and consolidation ([@bib3], [@bib10], [@bib16], [@bib30]). Arc is required for protein-synthesis-dependent synaptic plasticity related to learning and memory, making it one of the key molecular players in cognition ([@bib26], [@bib32], [@bib38]). Arc protein expression is highly dynamic: increasing and then rapidly declining following increased network activity or exposure to a novel environment ([@bib10], [@bib31]). Retrieval of a memory also induces Arc expression which then rapidly decays ([@bib24], [@bib31]). The regulation of Arc protein induction occurs at the level of mRNA transcription, mRNA trafficking, and protein translation ([@bib14]). Although the importance of Arc induction is clear, the role of Arc protein degradation in synaptic plasticity and learning-related behaviors is still unknown.

To determine the importance of Arc removal, we generated a mutant mouse line (ArcKR) in which ubiquitin-dependent degradation of Arc is disabled. We show that ArcKR mice display impaired cognitive flexibility that is coupled with elevated levels of Arc protein expression, a reduced threshold to induce mGluR-LTD, and enhanced mGluR-LTD. We further show that behavioral training alters *Arc* mRNA expression and modulates the magnitude of mGluR-LTD.

Results {#sec2}
=======

Ubiquitin-Dependent Turnover of Arc Alters AMPA Receptor Trafficking {#sec2.1}
--------------------------------------------------------------------

Arc promotes AMPA receptor (AMPAR) endocytosis following activation of group I mGluRs with the agonist DHPG ([@bib38]). This effect is reduced by overexpression of Triad3A/RNF216, which targets Arc for degradation. Conversely, Triad3A/RNF216 depletion increases Arc levels, thus enhancing AMPAR endocytosis ([@bib18]). We recorded mEPSCs in neurons expressing short hairpin RNA (shRNA) directed against Triad3A/RNF216 ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Depletion of Triad3A/RNF216 significantly (p = 0.026, [Figure S1](#mmc1){ref-type="supplementary-material"}A) enhanced DHPG-dependent reduction in AMPAR-mediated mEPSC amplitude within 2--3 min compared to neurons expressing a scrambled shRNA.

Triad3A/RNF216 and Ube3A E3 ligases ubiquitinate Arc on lysines 268 and 269, targeting Arc for proteasome-mediated degradation ([@bib9], [@bib18]). To confirm that ubiquitination of Arc modulates surface AMPAR expression, we transfected hippocampal neurons with either Arc-WT, Arc-2KR (K268/269R), or Arc-5KR (K55/136/268/269/293R) and then stained for the surface AMPAR subunit, GluA1 ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Overexpression of the Arc-KR mutants (Arc-2KR or Arc-5KR) had comparable effects, both producing a greater decrease in surface GluA1 expression compared to Arc-WT. Thus, a reduction in Arc protein degradation enhances GluA1 internalization ([Figure S1](#mmc1){ref-type="supplementary-material"}C) and suggests that expression of a degradation-resistant Arc protein would augment AMPAR endocytosis *in vivo*.

Enhanced mGluR-LTD in the Hippocampus of ArcKR Mice {#sec2.2}
---------------------------------------------------

We next created an Arc knockin mouse (ArcKR) where lysine 268 and 269 were mutated to arginine to prevent Arc ubiquitination ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B). ArcKR mice were born with expected Mendelian ratios, with no differences in mortality rate or in weight of heterozygous or homozygous *Arc*^*KR/KR*^ (ArcKR) mice compared to *Arc*^*+/+*^ (WT) littermates. There were no significant differences in the expression of various scaffold proteins, NMDA receptors, or AMPAR subunits in synaptosomes ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). Expression levels of mGluR1/5 and Arc protein were similar in WT and ArcKR mice as was *Arc* mRNA ([Figures S2](#mmc1){ref-type="supplementary-material"}C--S2F). To confirm that proteasome-mediated turnover of Arc was impaired, we monitored Arc protein levels following addition of DHPG (100 μM, 10 min), which induces Arc translation and ubiquitination ([@bib13], [@bib38]). In WT neurons, addition of DHPG increased Arc protein, peaking at 120 min post-induction and decaying near baseline levels at 480 min ([Figure 1](#fig1){ref-type="fig"}A). Addition of DHPG to ArcKR hippocampal neurons resulted in persistent Arc protein elevation ([Figures 1](#fig1){ref-type="fig"}A and 1B). To measure Arc degradation, we applied the protein synthesis inhibitor anisomycin after DHPG to halt Arc protein synthesis. In WT neurons, Arc levels were reduced after anisomycin treatment ([Figure 1](#fig1){ref-type="fig"}C), consistent with rapid Arc degradation. In contrast, this decline was significantly blunted in ArcKR neurons ([Figure 1](#fig1){ref-type="fig"}D), demonstrating the importance of proteasomal degradation in limiting the half-life of Arc protein. We have demonstrated that Arc ubiquitination via K48 linkages could be elicited by pilocarpine-induced seizures *in vivo* ([@bib18]). Pilocarpine-induced seizures in WT mice resulted in an increase in K48-linked Arc ubiquitination, an effect that was attenuated in ArcKR mice ([Figure 1](#fig1){ref-type="fig"}E).Figure 1ArcKR Mice Exhibit Defects in Ubiquitin-Mediated Turnover of Arc(A and B) Blots showing increased Arc protein in ArcKR hippocampal cultures treated with DHPG (100 μM DHPG; 10 min) and harvested 15, 30, 60, 120, 240, 360, and 480 min after DHPG washout.(C) Blots showing that Arc turnover is faster in WT neurons.(D) Blots showing that Arc turnover is blunted in ArcKR neurons.(E) Blot of K48-linked ubiquitin showing loss of Arc ubiquitination in ArcKR mice after pilocarpine induced class III seizure. Actin was used as a loading control.(F and G) ArcKR neurons have increased GluA1 endocytosis. Odyssey CLx scans for surface and internalized AMPAR subunits in WT and ArcKR hippocampal neurons at 5 and 15 min after DHPG washout (F). Graph represents surface fluorescence normalized to the total fluorescence intensity (G).(H and I) The same experimental condition as in (G) showing that ArcKR neurons have increased surface levels of GluA2. Statistical comparisons were carried out using one-way ANOVA, paired and unpaired Student's t tests. ^∗^p ≤ 0.05; ^∗∗^p ≤ 0.005; n = 3 technical replicates from 3 independent experiments. Values represent mean ± SEM.

Consistent with the reduced surface expression of GluA1, we observed increased GluA1 endocytosis in ArcKR neurons treated with DHPG using a high-content AMPA receptor trafficking assay ([Figures 1](#fig1){ref-type="fig"}F and 1G). Intriguingly, we found a significant increase in the surface expression of the GluA2 subunit in ArcKR neurons, at short time points, indicating a potential receptor subunit replacement ([Figures 1](#fig1){ref-type="fig"}H and 1I). These findings support our previous observation that overexpression of ArcWT in hippocampal neurons increases the rectification index of AMPAR-mediated miniature-EPSC amplitude, indicating an increase in the proportion of AMPAR-containing GluA2 subunits ([@bib6], [@bib37]).

Given the increase in GluA1-containing AMPAR endocytosis rates, we speculated that mGluR-LTD would be enhanced, as this form of plasticity requires Arc-dependent AMPAR internalization ([@bib26], [@bib38]). Basal synaptic transmission and synaptic plasticity were measured in hippocampal slices from ArcKR and WT littermates. ArcKR mice had unaltered basal synaptic transmission: no significant (p \> 0.05) change in paired-pulse facilitation ([Figure 2](#fig2){ref-type="fig"}A), input-output relationship ([Figure 2](#fig2){ref-type="fig"}B), or ratio of fEPSP slope to volley amplitude ([Figure 2](#fig2){ref-type="fig"}B, inset). Thus, under basal conditions, Arc ubiquitination has little effect on synaptic AMPAR expression consistent with no changes in protein and mRNA expression ([Figures S2](#mmc1){ref-type="supplementary-material"}C, S2D, and S2F). To investigate the role of Arc degradation in synaptic plasticity, we induced mGluR-LTD with DHPG (100 μM, 10 min) in hippocampal slices from ArcKR and WT littermates. We observed no significant difference between genotypes (p = 0.29) when DHPG was present. However, LTD was significantly enhanced in ArcKR mice (55--60 min after DHPG washout, [Figures 2](#fig2){ref-type="fig"}C and 2D). To test whether the threshold to induce LTD is reduced in ArcKR slices, we applied a lower concentration of DHPG (50 μM, 10 min). This lower concentration of DHPG was insufficient to induce LTD in WT mice but was sufficient to induce LTD in slices from ArcKR mice ([Figures 2](#fig2){ref-type="fig"}E and 2F). Thus, reduction of Arc ubiquitination reduces the threshold to induce LTD and enhances the magnitude of mGluR-LTD.Figure 2Defects in Arc Ubiquitination Enhance mGluR-LTD(A) Mean paired-pulse ratio against paired-pulse interval for WT (n = 12 slices) and ArcKR mice (n = 10 slices). Inset: representative traces at an interval of 50 ms from WT and ArcKR littermates.(B) Mean fEPSP slope against stimulus strength for WT (n = 9 slices) and ArcKR mice (n = 10 slices) with examples of superimposed averaged fEPSPs at different stimulus strengths. Inset: ratio of fEPSP slope versus volley amplitude at 40% of the stimulus strength that gives the maximum fEPSP slope (n = 6 slices per genotype).(C) Normalized mean fEPSP slope against time for WT and ArcKR mice. After a 20 min baseline, DHPG (100 μM) was applied for 10 min and then washed out for 1 hr. Baseline fEPSP slope was analyzed at 15--20 min and LTD was analyzed at 55--60 min after DHPG application (fEPSP slope was significantly reduced following DHPG, ArcKR, p = 0.00016; WT, p = 0.00013, fEPSPs were not normalized). LTD was significantly enhanced in ArcKR slices versus WT littermates (WT: 74.3% ± 3%, n = 5 animals, 9 slices; ArcKR: 49.5% ± 4.3%, 5 mice, 12 slices, p = 0.0004, fEPSPs were normalized to baseline). fEPSP traces (averages of 10 fEPSPs) were taken at the times indicated by the numerals in the plot below.(D) Mean percentage reduction in fEPSP slope (LTD) between 55 to 60 min after DHPG application (p = 0.015).(E) Normalized mean fEPSP slope against time for WT and ArcKR mice. Slices were treated as in (C). In ArcKR slices, fEPSP slope was significantly reduced after 55--60 min of 50 μM DHPG application (p = 0.0046) but was not significantly (p = 0.41) reduced in WT slices (fEPSPs were not normalized). fEPSP traces (averages of 10 fEPSPs) were taken at the numerals in the lower plot.(F) LTD was not induced in WT mice by 50 μM DHPG (reduction in slope 1.8% ± 7.7%, n = 3 mice, 5 slices) but was induced in ArcKR littermates (reduction 28% ± 11%, 3 mice, 5 slices, p = 0.04). Values represent mean ± SEM. Statistical comparisons were carried out with one-way ANOVA, paired and unpaired Student's t tests.

ArcKR Mice Exhibit Cognitive Inflexibility and Reduced Threshold to Induce mGluR-LTD {#sec2.3}
------------------------------------------------------------------------------------

We considered whether ArcKR mice displayed behavioral deficits. WT and ArcKR mice had no overt motor abnormalities, similar anxiety levels ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3F) and recognition memory ([Figures S3](#mmc1){ref-type="supplementary-material"}G--S3I).

We next explored the role of Arc ubiquitination in hippocampal-dependent spatial learning by using a modified Barnes maze ([@bib7]). Mice were tested for 21 consecutive days to test acquisition, consolidation, and expression phases of learning (days 1--15). On day 16, the platform was rotated 180°, requiring the mice to learn a new location for the exit hole ([Figure S4](#mmc1){ref-type="supplementary-material"}A). No differences were observed in spatial acquisition during days 1--15 ([Figures 3](#fig3){ref-type="fig"}A and 3B). Following 180° rotation of the exit hole on day 16, there was no significant difference in distance traveled ([Figure 3](#fig3){ref-type="fig"}A), but there was a significantly higher number of errors ([Figure 3](#fig3){ref-type="fig"}B, reversal, p = 0.02) and selective perseverance bias ([Figure 3](#fig3){ref-type="fig"}C, p = 0.05) in ArcKR mice during the reversal phase (days 16--21). However, there was no difference in quadrant bias ratios during the acquisition phase ([Figure 3](#fig3){ref-type="fig"}C). This suggests that ArcKR mice show impairments in performing the task specifically during reversal learning. We next examined the strategy used to search for the maze exit hole ([Figure 3](#fig3){ref-type="fig"}D; [Figure S4](#mmc1){ref-type="supplementary-material"}B). Both WT and ArcKR mice showed a similar shift from a combination of random and serial strategies to a spatial search strategy (days 1--15; [Figure 3](#fig3){ref-type="fig"}D). However, when the maze exit was rotated 180° (reversal learning), there were clear differences in the search strategy employed by WT and ArcKR mice. On the day of reversal, WT and ArcKR mice used similar search strategies to the first day of training (day 1) ([Figures 3](#fig3){ref-type="fig"}D and 3E; [Figure S4](#mmc1){ref-type="supplementary-material"}C). However, in subsequent days, WT mice replaced random and serial for a spatial search strategy (as observed for the training before reversal). In contrast, ArcKR mice only employed a serial search strategy on days 17--19 (2--3 days following reversal), before utilizing a combination of strategies on days 20 and 21 ([Figures 3](#fig3){ref-type="fig"}D and 3E; [Figure S4](#mmc1){ref-type="supplementary-material"}C). Taken together, ArcKR mice are unable to reuse strategic approaches previously acquired during task learning, suggesting cognitive inflexibility.Figure 3ArcKR Mice Have Impaired Cognitive Flexibility(A) Distances traveled by WT and ArcKR mice during Barnes maze training.(B) Number of errors in WT and ArcKR mice during learning (days 1--15) and reversal phase (days 16--21).(C) Top: average quadrant bias. Bottom: perseverance ratio for WT and ArcKR mice during learning and reversal phase.(D) Percentage time that WT and ArcKR mice used random (brown), serial (gray), and spatial (black) search strategies (n = 5 mice for WT and ArcKR).(E) Average frequency of strategy used in (D). Two-way ANOVA, post hoc Fisher's LSD, ^∗^p ≤ 0.05, ^∗∗^p ≤ 0.005.(F) Normalized mean fEPSP slope against time for Barnes maze trained WT and ArcKR mice. Baseline fEPSP slope was analyzed at 15--20 min, LTD induction was analyzed at 0--5 min after DHPG and LTD expression analyzed at 55--60 min after DHPG application. Both LTD induction (^∗∗^p \< 0.001) and expression (WT: 78.8% ± 4.4%, n = 3, 5 slices; ArcKR: 58.1% ± 4.9%, n = 3, 7 slices, p = 0.0003) were significantly enhanced in trained ArcKR compared to WT mice. Top: representative fEPSP traces (averages of 10 fEPSPs) at the times indicated (1, 15--20 min and 2, 75--80 min).(G) Comparison of hippocampal *Arc* mRNA after 1, 15, or 21 days of training in the Barnes maze. *Arc* mRNA was normalized to the geometric mean of 2 genes (GAPDH and GPI) and *Arc* in the mouse with the highest expression after 1 day of training was set to 1 for the WT mice. Each data point represents triplicate measurements from an individual mouse. (WT 1day: n = 5; WT 15 days: n = 5; WT 21 days: n = 4; ArcKR 1 day: n = 6; ArcKR 15 days: n = 7; ArcKR 21 days: n = 5). ^∗^p = 0.07, ^∗∗^p = 0.025, ^∗∗∗^p = 0.001.(H) *Grm5* mRNA in WT and ArcKR mice after training. Values represent mean ± SEM. Statistical comparisons were carried out with one-way ANOVA, paired and unpaired Student's t tests.

Reversal Learning Training Impacts on mGluR-LTD {#sec2.4}
-----------------------------------------------

To address whether training of a spatial-dependent task (Barnes maze) had an impact on Arc expression and subsequent hippocampal synaptic plasticity, we used hippocampi of trained WT and ArcKR littermates to either measure Arc mRNA and protein expression or to measure mGluR-LTD. Compared to WT, we observed a significantly larger decrease in the fEPSP slope during DHPG application in slices from trained ArcKR mice (p \< 0.001, [Figure 3](#fig3){ref-type="fig"}F), and the expression of LTD was significantly increased in ArcKR slices ([Figures 3](#fig3){ref-type="fig"}F). Consistent with the enhanced decrease in the amplitude of fEPSPs during DHPG application, the levels of Arc protein were also significantly increased in hippocampal lysates obtained from ArcKR, but not from WT mice ([Figure S4](#mmc1){ref-type="supplementary-material"}D). Barnes maze training of WT and ArcKR mice for 15 days resulted in a significant reduction in *Arc* mRNA ([Figure 3](#fig3){ref-type="fig"}G) with no change in *Grm5* mRNA levels ([Figure 3](#fig3){ref-type="fig"}H) compared to the first day of training. This expression was not different between WT and ArcKR mice, indicating that *Arc* mRNA dynamics are not altered during spatial learning as has been observed in other Arc transgenic mouse models ([Figure 3](#fig3){ref-type="fig"}G) ([@bib34]). Intriguingly, we found that reversal learning led to an increase in *Arc* mRNA in ArcKR mice, suggesting delayed dynamics in *Arc* mRNA induction that mirrored the learning deficits in ArcKR mice during reversal learning ([Figures 3](#fig3){ref-type="fig"}D and 3G).

To determine the effect that Barnes maze training on basal synaptic transmission and mGluR-LTD, we recorded interleaved slices from trained and naive WT and ArcKR littermates ([Figure 4](#fig4){ref-type="fig"}). Training had no effect on basal synaptic transmission in either WT or ArcKR mice ([Figure 4](#fig4){ref-type="fig"}A). However, training significantly reduced mGluR-LTD in both trained genotypes ([Figures 4](#fig4){ref-type="fig"}B and 4C). This reduction was not presynaptic (no change in paired-pulse ratios prior to and after DHPG application in trained versus naive mice, [Figure 4](#fig4){ref-type="fig"}). In ArcKR-trained slices, there was a decrease in fEPSP amplitude during DHPG application, an observation that was not seen in WT mice ([Figure 4](#fig4){ref-type="fig"}B and 4C). These findings suggest that the temporal dynamics of Arc protein expression, induced by behavioral training, modulates subsequent mGluR-LTD.Figure 4Reversal Learning Training Impacts on mGluR-LTD(A) Top panels: mean paired-pulse ratio (PPR) plotted against paired pulse interval for WT (untrained n = 8 slices; trained n = 10 slices) and ArcKR mice (untrained n = 8 slices; trained n = 10 slices). Bottom panels: graphs plotting mean fEPSP slope against stimulus strength for WT (untrained n = 6 slices; trained n = 7 slices) and ArcKR mice (untrained n = 6 slices; trained n = 8 slices).(B and C) Normalized mean fEPSP slope against time for WT (trained versus untrained) and ArcKR (trained versus untrained) mice. In WT and ArcKR mice, reversal learning significantly reduced mGluR-LTD (WT, reduction in fEPSP slope: untrained mice 39% ± 3.6%, n = 3, 7 slices; trained mice 21.3% ± 3.5%, n = 3, 6 slices, p = 0.0017; ArcKR, reduction in fEPSP slope untrained 59.9% ± 3.6%, n = 3, 7 slices; trained 47.3% ± 1.8%, n = 3, 6 slices, p = 3.9 × 10^−13^). Inset graphs: mean PPR plotted against paired-pulse interval for WT (untrained n = 8 slices; trained n = 10 slices) and ArcKR mice (untrained n = 8 slices; trained n = 10 slices) following LTD. Inset: traces at an interval of 20 ms from WT and ArcKR littermates. Values represent mean ± SEM. Statistical comparisons were carried out with a one-way ANOVA, paired and unpaired Student's t tests.

Discussion {#sec3}
==========

Arc protein expression is exquisitely regulated by neuronal activity. Here we have determined the functional consequences of modifying the temporal profile of Arc expression. Using a novel mouse (ArcKR) we showed: (1) mGluR1/5-dependent induction of Arc protein enhances GluA1-containing AMPAR endocytosis; (2) enhanced mGluR-LTD and a reduced threshold to induce LTD; (3) deficits in selecting strategies to perform the reversal of a spatial learned task that is coupled to the changes in LTD; and (4) increased *Arc* mRNA expression is associated with reversal learning.

Previous studies have linked alterations of mGluR-LTD to changes in spatial learning and task reversal ([@bib7], [@bib23], [@bib40]). Since deficits in mGluR-LTD are associated with impairment of the acquisition/consolidation of spatial learning and poor performance with task reversal ([@bib7], [@bib22], [@bib40]), it might be predicted that ArcKR mice, which show enhanced mGluR-LTD, would exhibit improved spatial learning. However, this was not the case, with ArcKR mice showing specific defects in reversal learning strategies. Instead of using a combination of random, serial, and spatial strategies, as observed in WT, ArcKR mice relied primarily on a serial strategy resulting in more errors during task reversal. These mice are unable to engage multiple strategic approaches and thus lack the cognitive flexibility required to efficiently complete the task.

How does the enhancement of LTD lead to specific cognitive deficits? During reversal learning, memories of the previously learned task are updated as new memories are acquired ([@bib20]). Neural representation of such memory updating requires a precise balance between synaptic depression and potentiation ([@bib35]). If the amplitude of the depression is too high (i.e., enhanced LTD) or occurs too early (due to a lower threshold), this might delay or prevent the acquisition of new memories. Conversely, if LTD is impaired, this could prevent the updating of memories acquired during the acquisition phase, interfering with task reversal. Intriguingly, defects in these forms of plasticity are observed in neurological disease models, which are associated with elevated levels of Arc, (e.g., Fragile X syndrome, Angelman syndrome, and Alzheimer's disease) ([@bib2], [@bib9], [@bib21], [@bib27], [@bib39]). Thus, an optimal balance of protein translation, synthesis, and turnover is required for the correct expression of mGluR-LTD and learning behavior ([@bib4], [@bib12], [@bib13]).

The degree of inhibition produced by low concentrations of DHPG (50 μM) was the same in both genotypes, suggesting similar activation of mGluRs and downstream pathways, but LTD was only produced in ArcKR slices. It seems likely that Arc is degraded in WT mice and does not reach a sufficient concentration to induce LTD, whereas in ArcKR mice, Arc persists, and thus induces LTD. The amplitude of mGluR-LTD is enhanced in ArcKR mice and has a postsynaptic origin, as there were no changes in paired-pulse facilitation. This is further supported by an increased internalization of the GluA1-containing AMPAR subunit in ArcKR neurons after DHPG exposure ([Figures 1](#fig1){ref-type="fig"}F--1I). Corroborating this hypothesis is the observation that there is a significant reduction in the rectification index of AMPAR-mediated mEPSC amplitude in neurons overexpressing Arc, indicating a reduction in the number of GluA1-containing AMPAR subunits at synapses ([@bib6], [@bib37]).

There were no changes in Arc protein or *Arc* mRNA levels between genotypes under basal conditions ([Figures S2](#mmc1){ref-type="supplementary-material"}C, S2D, and S2F), consistent with the lack of differences in basal synaptic transmission ([Figures 2](#fig2){ref-type="fig"}A and 2B). Similar to previous reports ([@bib11]), we found that prolonged behavioral training reduced *Arc* mRNA levels ([Figure 3](#fig3){ref-type="fig"}G), although there were no changes in Arc protein expression ([Figure S4](#mmc1){ref-type="supplementary-material"}E). This may reflect a fall in transcription rate, a loss of mRNA, or the slow degradation of protein. Following completion of the reversal task, there was a significant increase in *Arc* mRNA and Arc protein in ArcKR mice ([Figure 3](#fig3){ref-type="fig"}G; [Figure S4](#mmc1){ref-type="supplementary-material"}E). Interestingly, the amplitude of LTD was reduced in both WT and ArcKR mice following behavioral training when compared to naive littermates ([Figures 4](#fig4){ref-type="fig"}B and 4C). This did not appear to be a consequence of changes in *Grm5* mRNA expression. The mechanism for this reduction in LTD is unclear but is likely postsynaptic, as no changes in paired pulse ratios were observed ([Figures 4](#fig4){ref-type="fig"}B and 4C). A possible explanation is that the increased expression of Arc, induced during the reversal task, partially occludes subsequent depression through a feedback mechanism that reduces induction of Arc or altered signaling pathways downstream of Arc.

Although Arc ubiquitination was attenuated in ArcKR mice ([Figure 1](#fig1){ref-type="fig"}E), there was no accumulation of Arc protein *in vivo* ([Figure S4](#mmc1){ref-type="supplementary-material"}E). This suggests that this Arc ubiquitination pathway is not utilized as frequently during early stages of development. Alternatively, additional pathways might ubiquitinate Arc earlier in life and during specific phases of learning. Indeed, following stimulation of N-methyl-D-aspartate receptors, another unknown E3 ubiquitin ligase has been proposed to ubiquitinate Arc at an alternative lysine site, K136, leading to Arc degradation by the ubiquitin proteasome pathway ([@bib8], [@bib17]). However, this does not appear to be involved in AMPAR endocytosis as mutation of this site in addition to K268 and K269 did not further alter AMPAR internalization ([Figures S1](#mmc1){ref-type="supplementary-material"}B and S1C). An alternative interpretation is that the lysosome-dependent pathway regulates Arc degradation ([@bib25]).

Recent findings suggest that Arc protein and mRNA undergo self-intercellular transfer by assembling into virus-like capsids. This mechanism may require exosome secretion from one neuron and endocytic uptake by another ([@bib1], [@bib28]). A possible explanation for the moderate accumulation of Arc protein in ArcKR mice is that Arc ubiquitination participates in this transfer process. Evidence to support this hypothesis is highlighted by our recent findings demonstrating that the E3 ubiquitin ligase for Arc, Triad3A/RNF216 is enriched at clathrin-coated pits (CCPs), regions that participate in the endocytosis of cargo molecules. Recently, a point mutation in Arc (W197A) was shown to enhance binding to Triad3A but decrease interactions with AP-2 and dynamin ([@bib6]). These findings suggest another functional role for Arc/Triad3A interaction. Further evidence supporting these findings is that expression of the ArcKR mutant stays longer at the plasma membrane but rarely overlaps with CCPs, suggesting that Triad3A-dependent ubiquitination might couple Arc to endocytic regions ([@bib18]).

Our results reveal that disruption in the degradation of a single protein, Arc, is sufficient to enhance mGluR-LTD resulting in deficits in reversal learning strategy. Thus, manipulation of Arc longevity may be a strategy to restore synaptic plasticity defects in neurological disorders where Arc protein dynamics are disrupted.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rabbit polyclonal anti-Arc/Arg3.1Synaptic SystemsCat\#156 003, RRID: [AB_887694](nif-antibody:AB_887694){#intref0010}Mouse monoclonal (6C5) anti-GAPDHAbcamCat\#ab8245, RRID: [AB_2107448](nif-antibody:AB_2107448){#intref0015}Mouse monoclonal (MAB374) anti-GAPDHMilliporeCat\#MAB374, RRID: [AB_2107445](nif-antibody:AB_2107445){#intref0020}Mouse monoclonal (RH95) anti-GluA1 N-terminalEMD MilliporeCat\#MAB2263MI, RRID: [AB_11212678](nif-antibody:AB_11212678){#intref0025}Mouse monoclonal (6C4) anti-GluA2ThermoFisher ScientificCat\#32-0300, RRID: [AB_2533058](nif-antibody:AB_2533058){#intref0030}Rabbit polyclonal anti-mGluR1ASigmaCat\#G9665, RRID:[AB_259995](nif-antibody:AB_259995){#intref0035}Rabbit polyclonal anti-mGluR5EMD MilliporeCat\#AB5675, RRID:[AB_2295173](nif-antibody:AB_2295173){#intref0040}Goat polyclonal anti-NR1Santa Cruz BiotechnologyCat\#sc-1467, RRID: [AB_670215](nif-antibody:AB_670215){#intref0045}Goat polyclonal anti-NR2BSanta Cruz BiotechnologyCat\#sc-1469, RRID: [AB_670229](nif-antibody:AB_670229){#intref0050}Rabbit polyclonal anti-PSD95Synaptic SystemsCat\#124 002, RRID: [AB_887760](nif-antibody:AB_887760){#intref0055}Mouse monoclonal (GT5512) anti-β-ActinGenetexCat\#GTX629630, RRID: [AB_2728646](nif-antibody:AB_2728646){#intref0060}Donkey anti-mouse Alexa Fluor 555Thermo Fisher ScientificCat\#A31570, RRID [AB_2536180](nif-antibody:AB_2536180){#intref0065}Donkey anti-rabbit Alexa Fluor 488Jackson ImmunoResearchCat\#715-545-150, RRID: [AB_2340846](nif-antibody:AB_2340846){#intref0070}IRDye 680RD Goat anti-Mouse IgG (H+L)Li-COR BiosciencesCat\# 926-68070, RRID: [AB_10956588](nif-antibody:AB_10956588){#intref0075}IRDye 800CW Goat anti-Rabbit IgG (H+L)Li-COR BiosciencesCat\# 926-32211, RRID: [AB_621843](nif-antibody:AB_621843){#intref0080}IRDye 800CW Donkey anti-Mouse IgG (H+L)Li-COR BiosciencesCat\# 926-32212, RRID: [AB_621847](nif-antibody:AB_621847){#intref0085}Goat anti-rabbit IgG HRP-linked antibodyCell Signaling TechnologyCat\#7074, RRID: [AB_2099233](nif-antibody:AB_2099233){#intref0090}Goat anti-mouse IgG HRP-linked antibodyJackson Immuno- ResearchCat\#115-035-174, RRID: [AB_2338512](nif-antibody:AB_2338512){#intref0095}**Chemicals, Peptides, and Recombinant Proteins**PapainWorthington BiochemicalsCat\#LS003126Deoxyribonuclease I from bovine pancreasSigma-AldrichCat\# D4513Poly-L-lysineSigma-AldrichCat\#P2636-100MGcytosine β-D-arabinofuranosideSigma-AldrichCat\# C1768-100MGAnisomycinSigma-AldrichCat\#A9789, CAS 22862-76-6Fluoromount aqueous mounting mediumSigma-AldrichCat\#F4680-25MLcOmplete, Mini, EDTA-free Protease Inhibitor CocktailSigma-AldrichCat\#11836170001Phosphatase Inhibitor Cocktail 2Sigma-AldrichCat\#P5726PicrotoxinTocris Bio-TechneCat\#1128, CAS 124-87-8L689,560Tocris Bio-TechneCat\# 0742/10, CAS 139051-78-8(RS)-3,5-DHPGTocris Bio-TechneCat\#0342, CAS 19641-83-9Tetrodotoxin citrateTocris Bio-TechneCat\#1069, CAS 18660-81-6RNAlaterQIAGENCat\#76104QIAshredderQIAGENCat\#79654RNase-Free DNase SetQIAGENCat\#79254TRIzolThermoFisher ScientificCat\#12044977Normal donkey serumJackson ImmunoResearchCat\#017-000-121Odyssey Blocking Buffer (TBS)Li-CORCat\#927-50003SaponinACROS OrganicsCat\# 419231000, CAS 74499-23-3**Critical Commercial Assays**RNeasy Lipid Tissue Mini KitQIAGENCat\#74804Transcriptor First Strand cDNA Synthesis KitRocheCat\#04379012001PowerUp SYBR Green Master MixThermoFisher ScientificCat\#15350929ECL Supersignal West PicoThermoFisher ScientificCat\#34080BCA Protein Assay kitThermoFisher ScientificCat\#23225Lipofectamine 2000 Transfection ReagentThermoFisher ScientificCat\#11668027**Oligonucleotides**ARC-KI-NDEL1: cttattggagtatgtgccatttctcThis paper, genotypingN/AARC-KI-NDEL2: cattgaccctgtctccagattcThis paper, genotypingN/AArc-L: tgttgaccgaagtgtccaagThis paper, qPCRN/AArc-R: aagttgttctccagcttgccThis paper, qPCRN/AmGluR5-L: cagtccgtgagcagtatggThis paper, qPCRN/AmGluR5-R: gcccaatgactcccactaThis paper, qPCRN/AGAPDH-L: ggcaaattcaacggcacagtThis paper, qPCRN/AGAPDH-R: gggtctcgctcctggaagatThis paper, qPCRN/AmGPI-L: agctgcgcgaactttttgagThis paper, qPCRN/AmGPI-R: tatgcccatggttggtgttgThis paper, qPCRN/A**Recombinant DNA**prK5-myc-Arc[@bib18]N/AprK5-myc-ArcKR[@bib18]N/AprK5-myc-Arc-5KR[@bib18]N/ApLentilox 3.7 LL-Scramble control shRNA[@bib18]N/ApLentilox 3.7 LL-*Triad3/RNF216*-shRNA \#2[@bib18]N/A**Software and Algorithms**Primer3Plus[@bib36]<http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi>StepOne PlusApplied BiosystemsN/ASPSS 22IBMN/AAny-MAZEStoelting<https://www.stoeltingco.com>; RRID: SCR_014289OriginMicrocal<https://www.originlab.com/>; RRID: SCR_002815Multiclamp 700BMolecular DevicesN/ADigidata 1440AMolecular DevicesN/ApClamp 10Molecular DevicesRRID: SCR_011323MiniAnalysis ProgramSynaptoSoft<http://www.synaptosoft.com/MiniAnalysis>; RRID: SCR_002184Spike 2 Vs 7.08Micro CED<http://ced.co.uk/products/spkovin>; RRID: SCR_000903ImageJNIH<https://imagej.nih.gov/ij/>; RRID: SCR_003070FIJI (Fiji is Just ImageJ)NIH<http://fiji.sc/>; RRID: SCR_002285

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

As Lead Contact, Angela M. Mabb is responsible for all reagent and resource requests. Please contact Angela M. Mabb at <amabb@gsu.edu> with requests and inquiries.

Method Details {#sec4.3}
--------------

### Animals {#sec4.3.1}

Mice were kept in standard housing with littermates, provided with food and water *ad libitum* and maintained on a 12:12 (light-dark) cycle. All behavioral tests were conducted in accordance with the *National Institutes of Health Guidelines for the Use of Animals*. All behavioral studies with the exception of the Barnes Maze test were conducted using approved protocols at the University of North Carolina, Chapel Hill. The Barnes Maze test and the hippocampal slice experiments were performed at the University of Warwick. The mice were treated in accordance with the Animal Welfare and Ethics Committee (AWERB) and experiments were performed under the appropriated project licenses with local and national ethical approval. Samples sizes for behavioral and slice experiments were calculated using variance from previous experiments to indicate power, which statistical analysis significance was set at 95%. Primary neuron culture, pilocarpine seizure experiments, and isolation of brain tissue for biochemical experiments were approved by the Georgia State University Institutional Animal Care and Use Committee.

### Generation of Arc knockin mice {#sec4.3.2}

Arc knockin mice were produced by the ingenious targeting laboratory (Ronkonkoma, NY). Gene targeting was performed in iTL IC1 (C57BL/6) ES cells to introduce 2 point mutations within Exon 1 of the *Arc* gene. When encoded, the introduction of these point mutations leads to a substitution of Lysine to Arginine in positions 268 and 269, sites that were previously identified as being ubiquitinated by Triad3A and Ube3a ([@bib9], [@bib18]). ES cells were screened and positive clones were microinjected into BALB/c blastocysts and transferred to pseudopregnant female mice. Resulting chimeras with a high percentage black coat color were mated to C57BL/6 FLP mice to remove the Neo cassette, and backcrossed five times to C57/BL6 mice. *Arc*^*+/+*^ (WT) were distinguished from *Arc*^*KR/KR*^ (ArcKR) homozygous mice by genotyping for the presence of the one remaining FRT site after Neo deletion using the following primer sets: ARC-KI-NDEL1: 5′-cttattggagtatgtgccatttctc-3′ (Primer 1) and ARC-KI-NDEL2: 5′-cattgaccctgtctccagattc-3′ (Primer 2) where the wild-type band size is 291 base pairs and the knockin band size is 355 base pairs.

### Primary neuron culture and cell treatment {#sec4.3.3}

Primary hippocampal neurons of mixed sex were isolated from P0-1 mice as previously described ([@bib5]). To assess Arc levels following mGluR-LTD, DIV12 - 14 primary hippocampal neurons were pre-treated with 2 μM TTX (Tocris) for 4 hr. TTX was washed out and 100 μm (*S*)-3,5-dihydroxyphenylglycine (DHPG, Tocris) was applied for a total of 10 min. Cells were harvested 45 min later following DHPG washout. To block protein synthesis of Arc, 20 μM anisomycin (Sigma) was added at the 45 min time point and cells were harvested 30, 60, and 120 min later.

The primary cortical neuron culture protocol was based on ([@bib33]). Cortices of mixed sex were dissected from E18 rat embryos. Cortices were dissociated in DNase (0.01%; Sigma-Aldrich) and papain (0.067%; Worthington Biochemicals), then triturated with a fire-polished glass pipette to obtain a single-cell suspension. Cells were pelleted at 1000x*g* for 4 min, the supernatant removed, and cells resuspended and counted with a TC-20 cell counter (Bio-Rad). Neurons were plated on glass coverslips (Carolina Biological Supply, Burlington, NC) coated with poly-l-lysine (0.2 mg/mL; Sigma-Aldrich) in 12-well plates (Greiner Bio-One) at 100,000 cells/mL. Neurons were initially plated in Neurobasal media containing 5% horse serum, 2% GlutaMAX, 2% B-27, and 1% penicillin/streptomycin (Thermo Fisher Scientific) in a 37°C incubator with 5% CO~2~. On DIV4, neurons were fed via half media exchange with Neurobasal media containing 1% horse serum, GlutaMAX, and penicillin/streptomycin, 2% B-27, and 5 μM cytosine β-d-arabinofuranoside (AraC; Sigma-Aldrich). Neurons were fed every three days thereafter.

#### Neuron transfection {#sec4.3.3.1}

At DIV14, transfections were performed using Lipofectamine 2000 (Thermo Fisher Scientific) as described previously ([@bib33]). Immunostaining was performed 16 hr later.

#### Immunocytochemistry {#sec4.3.3.2}

At DIV15, transfected neurons were live-labeled for surface GluA1 receptors ([@bib33]). Neurons were washed twice at 10°C with 4% sucrose/1X phosphate-buffered saline (PBS; 10X: 1.4 M NaCl, 26.8 mM KCl, 62 mM Na~2~HPO~4~, 35.3 mM KH~2~PO~4~, pH 7.4), then incubated in anti-GluA1-NT diluted in MEM containing 2% GlutaMAX, 2% B-27, 15 mM HEPES (Thermo Fisher Scientific), 1 mM sodium pyruvate (Thermo Fisher Scientific), and 33 mM glucose at 10°C for 20 min. Neurons were then fixed for 15 min with 4% sucrose/4% paraformaldehyde (Thermo Fisher Scientific) in 1X PBS, then incubated in Alexa Fluor 555 (Thermo Fisher Scientific) to label only surface GluA1. Following this, neurons were permeabilized for 10 min with 0.2% Triton X-100 (Amresco) in 1X PBS, and blocked for 30 min in 5% normal donkey serum (Jackson ImmunoResearch) in 1X PBS. Neurons were then incubated with rabbit anti-Arc antibody (Synaptic Systems), diluted in block for 1 hr at RT, washed 3 × 5 min in 1X PBS, and incubated in secondary antibody (Alexa Fluor 488; Jackson ImmunoResearch) diluted in block for 1 hr at RT. Neurons on coverslips were mounted on glass slides in Fluoromount (Thermo Fisher Scientific) and dried overnight at RT.

#### Neuron imaging and analysis {#sec4.3.3.3}

A total of 15 transfected and untransfected neurons were imaged at 60X on an Olympus FV1000 confocal microscope (Tokyo, Japan). GluA1 immunostaining was analyzed using ImageJ software. The most intense immunostaining was used to set an arbitrary pixel intensity threshold, which was applied to every image in the experiment. Integrated density of each puncta in two 25-μm dendrite segments/neuron was measured and summed to obtain a total integrated density of the puncta on the dendritic segment.

#### High-content AMPA receptor trafficking assay {#sec4.3.3.4}

Primary hippocampal neurons were prepared as stated above and plated in 96-well microplates (Molecular Probes) at a density of 20,000 cells per well. Neurons were fed as previously described ([@bib5]). At DIV 14, neurons were treated with 2 μM TTX (Tocris) for 4 hr. Following treatment, neurons were cooled to room temperature and incubated with a 1:150 dilution of anti-GluA1 (Millipore, MAB2263MI) or anti-GluA2 (Invitrogen, Clone 6C4) antibody prepared in conditioned media. Neurons were incubated for 20 min at room temperature to allow antibody binding. Samples were washed 3 times with room temperature Neurobasal medium (GIBCO) and then treated with vehicle or 100 μm DHPG for 10 min. After 10 min, DHPG was washed out and neurons were fixed with 4% paraformaldehyde/4% sucrose in PBS for 20 min at 4°C. Neurons were then washed with 1X DPBS (GIBCO) and blocked in Odyssey Blocking Buffer (Li-COR) for 90 min at room temperature. To measure surface receptors, neurons were incubated for 1 hr in a 1:1,500 dilution of IRDye 680RD Goat anti-Mouse IgG (H+L) (Li-COR) secondary antibody. Neurons were then washed with TBS (50 mM Tris-HCl, 150 mM NaCl, pH7.6) 5 times and then fixed with 4% paraformaldehyde/4% sucrose in PBS for 20 min at 4°C. Neurons were then washed with TBS 2 more times and permeabilized in TBS containing 0.2% saponin (ACROS Organics) for 15 min at room temperature. Neurons were then blocked in Odyssey Blocking Buffer for 90 min at room temperature. To label the internalized pool of receptors, neurons were incubated for 1 hr in a 1:1,500 dilution of IRDye 800CW Donkey anti-Mouse IgG (H+L) (Li-COR) secondary antibody. Cells were then washed with TBS 5 times and imaged on the Odyssey Clx Imaging System (LI-COR) with a resolution of 84 μm, medium quality and a 3 mm focus offset. Images were processed in FIJI where ROIs were drawn on each well. The integrated density was measured on ROIs superimposed on the 680 (surface receptor pool) and 800 (internal receptor pool) channels individually. Experiments were run in triplicate and integrated density values for each channel in individual experimental wells were subtracted to a secondary only control. To calculate changes in surface receptor expression, the following calculation was used: R~S~/R~T~, where R~S~ represents the integrated density of surface receptors and R~T~ represents the integrated density of surface receptors + integrated density of internal receptors.

### Synaptosome preparation {#sec4.3.4}

Synaptosomes were prepared as previously described ([@bib18]). Briefly, hippocampi were dissected from male and female P21 WT and ArcKR mice. Hippocampi were lysed in 10 volumes of HEPES-buffered sucrose (0.32 M sucrose, 4 mM HEPES pH7.4 containing protease and phosphatase inhibitors (Roche) and homogenized using a motor driven glass-teflon homogenizer at ∼900 rpm (10-15 strokes). The homogenate was centrifuged at 800-1000 x g at 4°C to remove the pelleted nuclear fraction. The resultant supernatant was spun at 10,000 x g for 15 min to yield the crude synaptosomal pellet. The pellet was resuspended in 10 volumes of HEPES-buffered sucrose and then respun at 10,000 x g for another 15 min to yield the crude synaptosomal fraction. The resulting pellet was lysed by hypoosmotic shock in 9 volumes ice cold H~2~0 plus protease/phosphatase inhibitors (Roche) and three strokes of a glass-teflon homogenizer and rapidly adjusted to 4 mM HEPES using 1 M HEPES, pH 7.4 stock solution. Samples were mixed constantly at 4°C for 30 min to ensure complete lysis. The lysate was centrifuged at 25,000 x g for 20 min to yield a supernatant (crude synaptic vesicle fraction) and a pellet (lysed synaptosomal membrane fraction). The pellet was resuspended in HEPES-buffered sucrose and used for western analysis.

### Western blotting {#sec4.3.5}

Hippocampal lysate obtained from WT and ArcKR mice was prepared as previously described ([@bib7]). Western blots were performed as previously described ([@bib7], [@bib19]). Membranes were probed with the following antibodies: rabbit anti-Arc (Synaptic Systems, 1:1,000), goat anti-NR1 (Santa Cruz Biotechnology, 1:1,000), goat anti-NR2B (Santa Cruz Biotechnology, 1:1,000), mouse anti-GluA1 (EMD Millipore, Clone RH95, 1:500), mouse anti-GluA2 (Invitrogen, Clone 6C4, 1:500), rabbit anti-mGluR1A (Sigma, G9665, 1:500), rabbit anti-mGluR5 (EMDMillipore, AB5675, 1:500), rabbit anti-PSD-95 (Synaptic Systems, 1:1,000), mouse anti-β-Actin (Genetex, 1:5,000), mouse anti-GAPDH (Millipore, MAB374, 1:3,000 or Abcam, ab8245, 1:5,000). The following secondary antibodies were used: IRDye 680RD Goat anti-Mouse IgG (H+L) (Li-COR, 1:20,000), IRDye 800CW Goat anti-Rabbit IgG (H+L) (Li-COR, 1:15,000), IRDye 800CW Donkey anti-Goat IgG (H+L) (LI-COR, 1:15,000), Goat anti-Rabbit IgG-HRP H^+^L (Cell Signaling, 1:10,000) and Goat anti-Mouse IgG HRP LC (Jackson ImmunoResearch, 1:20,000). Blots were imaged using the Odyssey Clx Imaging System (LI-COR) or the ChemiDoc MP Imaging System (Bio-Rad).

### Pilocarpine-induced Arc ubiquitination assays {#sec4.3.6}

Pilocarpine seizures were induced in postnatal day 60--70 male and female WT and ArcKR mice as previously described ([@bib29]). Hippocampi from mice were harvested 30 min after the presence of Class III seizure onset. Arc protein ubiquitination was measured as previously described ([@bib18]).

### Quantitative PCR {#sec4.3.7}

#### RNA extraction and cDNA synthesis {#sec4.3.7.1}

Hippocampi from trained and naive WT and ArcKR mice were collected, submerged in RNAlater, and stored at −20°C until processed. The tissue was transferred into TRIzol reagent (Fisher Scientific), disrupted using sterile pestles and homogenized by passage through a QIAshredder column (QIAGEN). The homogenization was followed by chloroform phase separation and purification of the total RNA using the RNeasy Lipid Tissue Mini Kit (QIAGEN). Purified RNA was subjected to on-column DNase treatment (Fisher Scientific) and the concentration and purity of the RNA was assessed spectrophotometrically using the NanoDrop ND-1000 (NanoDrop). RNA used had an A~260~/A~280~ ratio of 1.9--2.25. First-strand cDNA synthesis was performed using the Transcriptor First Strand cDNA Synthesis Kit (Roche) using an anchored oligo(dT)~18~ primer, according to the manufacturer's protocol.

#### qPCR {#sec4.3.7.2}

Primers were designed with the help of Primer3Plus software ([@bib36]). qPCR was performed using a StepOnePlus Real-Time PCR System (Applied Biosystems, Life Technologies). Each reaction comprised of 2 μL of diluted cDNA, 5 μL PowerUp SYBR Green Master Mix (ThermoFisher) and 500 nM primers in a final volume of 10 μL. The PCR cycling conditions were as follows: 50°C for 2 min, 95°C for 2 min, then 40 cycles of 95°C for 15 s and 60°C for 1 min. Cycling was followed by melt curve recording between 60°C and 95°C. Primer standard curves were performed to estimate the PCR efficiencies for each primer pair. Cycle threshold (Ct) values were determined by the StepOne Plus software and adjusted manually. All qPCR reactions were run in duplicate (for analysis of P60 mice) or triplicate (for analysis of Barnes maze trained mice). A mean C~t~ value was calculated for each primer pair and each experimental condition. Relative quantification of *Arc* and *Grm5* mRNA was performed using the 2^-ΔΔCt^ method ([@bib15]). Data were normalized to the geometric mean of GAPDH and/or GPI (Glucose-6-Phosphate Isomerase) and presented as expression relative to a standard condition as indicated in the figure legends. Primer sequences are as follows: Arc-L tgttgaccgaagtgtccaag; Arc-R aagttgttctccagcttgcc; mGluR5-L cagtccgtgagcagtatgg; mGluR5-R gcccaatgactcccacta; GAPDH-L ggcaaattcaacggcacagt; GAPDH-R gggtctcgctcctggaagat; mGPI-L agctgcgcgaactttttgag; mGPI-R tatgcccatggttggtgttg.

### Mouse behavior {#sec4.3.8}

#### Behavior cohort {#sec4.3.8.1}

For behavior experiments, 12 WT and 12 ArcKR mice were used. Mice were sex balanced and housed separately by sex in groups of 4 (2 animals per genotype). No deaths occurred throughout the course of all behavioral studies. All behavioral tests were performed with the experimenter blinded to genotype.

#### Rotarod {#sec4.3.8.2}

8-week-old mice were tested for motor coordination and learning on an accelerating rotarod (Ugo Basile, Stoelting). For the first test session, mice were given three trials, with 45 s between each trial. Two additional trials were given 48 hr later. Rpm (revolutions per min) was set at an initial value of 3, with a progressive increase to a maximum of 30 rpm across 5 min (the maximum trial length). The latency to fall from the top of the rotating barrel was recorded.

#### Open field test {#sec4.3.8.3}

Exploratory activity in a novel environment was assessed in 8-week-old mice by a one-hour trial in an open field chamber (41 cm x 41 cm x 30 cm) crossed by a grid of photobeams (VersaMax system, AccuScan Instruments). Counts were taken of the number of photobeams broken during the trial in five-min intervals, with separate measures for locomotion (total distance traveled) and rearing movements. Time spent in the center region of the open field was measured as an index of anxiety-like behavior.

#### Elevated plus maze {#sec4.3.8.4}

The elevated plus maze was used to assess anxiety--like behavior, based on a natural tendency of mice to actively explore a new environment, versus a fear of being in an open area. Mice (7-week-old) were given one five-min trial on the plus maze, which had two walled arms (the closed arms, 20 cm in height) and two open arms. The maze was elevated 50 cm from the floor, and the arms were 30 cm long. Mice were placed on the center section (8 cm x 8 cm) and allowed to freely explore the maze. Measures were taken of time spent in, and number of entries into, the open and closed arms of the maze.

#### Marble-burying assay {#sec4.3.8.5}

To measure anxiety-like behaviors, 11-week-old mice were placed in a Plexiglas cage located in a sound-attenuating chamber with ceiling light and fan. The cage contained 5 cm of corncob bedding, with 20 black glass marbles (14 mm diameter) arranged in an equidistant 5 X 4 grid on top of the bedding. Subjects were given access to the marbles for 30 min. The number of marbles buried (defined by two thirds of the marble being covered by the bedding) was measured.

#### Novel object recognition test {#sec4.3.8.6}

Mice (22-week-old) were habituated in a Plexiglas cage containing 2 cm of corncob bedding for 30 min. 24 hr later (Acquisition phase), two of the same objects were placed in the same habituated cage containing 2 cm of corncob bedding. Mice were allowed to explore both objects for a total of 30 min. 24 hr later (Trial phase), one of the objects was replaced with a novel object and mice were allowed to explore both the familiar and novel object for a total of 30 min. Measurements of time spent with each object were scored during min 2 through 12 of the acquisition and trial phase. The Novel Object Recognition Index was calculated as the (Time spent with novel object/(Time spent with novel object + Time spent with familiar object)). Object interactions were defined as active interaction with the object where the mouse's nose was at least 1 cm pointed toward the object, time spent interacting/touching, and active sniffing of the object. Rearing on the objects was not scored. Exclusion criteria was set for \<30 s interaction with both objects during the acquisition phase. One WT and two ArcKR mice did not meet the criteria and were excluded from the analysis.

#### Barnes maze test {#sec4.3.8.7}

WT (24) and ArcKR male mice (27) aged 21-25 days were tested. Out of these 5 WT and 6 ArcKR mice were trained for 1 day, 5 WT and 7 ArcKR mice were trained for 15 days and 19 WT and 14 ArcKR were trained for 20-21 days. Spatial learning was assessed using a modified circular Barnes maze that measured 1 m in diameter, was situated 1 m from the floor, and contained 20 5-cm holes that were evenly spaced (5 cm) around the perimeter. The maze was positioned centrally within the lab, with surrounding equipment and architectural features kept in fixed positions, to act as spatial cues for learning. The maze contained an 'exit' box positioned under one of the holes and a "fake" box (incorporated to mimic light reflection from the exit box but with no depth) under another. The exit hole was randomly assigned on the first day and maintained in this position for 15 days for the "exit" box prior to the 180° shift (see below) and for the remaining 5-6 days of training. Each day, mice were randomly placed in the center of the maze, released, and allowed to explore the maze. The task was completed when the mouse entered the exit box. All runs were recorded using a camera system (Henelec Model 335 BWL SONY) attached to a computer for offline analysis (Any-MAZE v4.96, Stoelting). Total distance, speed, and accuracy of task performance were measured. On days 1-5, the exit box contained flavored treats as a reward for task completion. On days 6-21, treats were awarded in the home cage on completion to prevent cued orientation of the exit box location via olfactory stimulation. On days 16-21, the position of the exit box was rotated 180° to determine the spatial component of and coping ability for the task. Data analysis was carried out in a blind fashion, independently from the experimenter. Error number was measured by calculating the number of incorrect holes visited before locating the correct "exit" hole. Mapping the progression of the animals around the maze allowed determination of the search strategy. These were: random: no consistent pattern, \>2 crossings of the open field; serial: a hole-by-hole progression with ≥3 consecutive holes visited; and spatial: moving directly to the exit hole ± 2 holes and no deviation outside of the quadrant.

### Electrophysiology {#sec4.3.9}

#### AMPA receptor-mediated-miniature excitatory postsynaptic currents (mEPSCs) recorded in cultured neurons {#sec4.3.9.1}

Hippocampal neuronal cultures were prepared from postnatal day 0 pups from C57BL/6 wild-type mice as previously described ([@bib5]). Briefly, hippocampi were dissected from the brain, dissociated with trypsin, and approximately 10^5^ cells were plated onto 22-mm glass coverslips coated with poly-L-lysine in Neurobasal medium containing 1% L-glutamine, 1% penicillin-streptomycin, 2% B27 supplement (Invitrogen) and 5% horse serum. 24 hr after plating the media was completely changed and cells were grown in serum-free media. Cultures were maintained at 37°C and 5% CO~2~ in a humidified incubator and transfections of either scrambled or Triad3-shRNA ([@bib18]) were performed using Lipofectamine 2000 (Invitrogen). Cells expressing scrambled or Triad3-shRNA constructs were recorded at least 3-5 days after transfections. Coverslips were transferred to the recording chamber and perfused at a constant flow rate of (2 mL/min) with recording solution composed of (mM): 127 NaCl, 1.9 KCl, 1 MgCl~2~, 2 CaCl~2~, 1.3 K H~2~PO~4~, 26 NaHCO~3~, 10 D-glucose, pH 7.4 (when bubbled with 95% O~2~ and 5% CO~2~, 300 mOsm) at 28-30°C. Tetrodotoxin (Tocris, 1 μM), picrotoxin (50 μM, Tocris), and L-689,560 (5 μM, Tocris) were present in the recording solutions to isolate mEPSCs. To induce mGluR-dependent synaptic depression, (RS)-3,5-dihydroxyphenylglycine, (DHPG, 100 μM, Tocris) was bath applied for 10 min. Neurons were visualized using IR-DIC optics with an Olympus BX51W1 microscope and Hitachi CCD camera (Scientifica) at a total magnification of 400X. Whole-cell patch clamp recordings were made from transfected (identified by fluorescence at 488 nm) pyramidal neurons using patch pipettes (5-8 MΩ) made from thick walled borosilicate glass (Harvard Apparatus) filled with (mM): 135 potassium gluconate, 7 NaCl, 10 HEPES, 0.5 EGTA, 10 phosphocreatine, 2 MgATP, 0.3 NaGTP, pH 7.2, 290 mOsm. Recordings of mEPSCs were obtained at a holding potential of −75 mV using an Axon Multiclamp 700B amplifier (Molecular Devices), filtered at 3 kHz and digitized at 20 kHz (Digidata 1440A, Molecular Devices). Data acquisition was performed using pClamp 10 (Molecular Devices). Analysis of mEPSCs was performed using MiniAnalysis software (SynaptoSoft). Events were manually analyzed and were accepted if they had an amplitude \>5 pA (events below this amplitude were difficult to distinguish from baseline noise) and a faster rise than decay. Statistical significance was measured using a one-way ANOVA with 0.05% taken as significant.

### Hippocampal slice preparation {#sec4.3.10}

Hippocampal slices (400 μm) were obtained from 21 to 35 day-old WT and ArcKR littermates. For trained mice, slices were obtained up to 1 hr after the last training session. Animals were sacrificed by cervical dislocation and decapitated in accordance with the UK Animals (Scientific Procedures) Act (1986). The brain was rapidly removed and placed in ice-cold high Mg^2+^, low Ca^2+^ artificial CSF (aCSF), consisting of the following (in mM): 127 NaCl, 1.9 KCl, 8 MgCl~2~, 0.5 CaCl~2~, 1.2 KH~2~PO~4~, 26 NaHCO~3~, 10 D-glucose (pH 7.4 when bubbled with 95% O~2~ and 5% CO~2~, 300 mOSM). Parasagittal brain slices were then prepared using a Microm HM 650V microslicer in ice-cold aCSF (2-4°C). Slices were trimmed and the CA3 region was removed. Slices were allowed to recover at 34°C for 3-6 hr in aCSF (1 mM MgCl~2~, 2 mM CaCl~2~) before use.

### Extracellular recording from hippocampal slices {#sec4.3.11}

Field excitatory postsynaptic potentials (fEPSPs) were recorded from interleaved slices from WT and ArcKR littermates. An individual slice was transferred to the recording chamber, submerged in aCSF (composition as above), maintained at 32°C, and perfused at a rate of 6 mL/min. The slice was placed on a grid allowing perfusion above and below the tissue and all tubing was gas tight (to prevent loss of oxygen). To record fEPSPs, an aCSF filled microelectrode was placed on the surface of stratum radiatum in the CA1 region. A bipolar concentric stimulating electrode (FHC) controlled by an isolated pulse stimulator, model 2100 (AM Systems, WA) was used to evoke fEPSPs at the Schaffer collateral--commissural pathway. All recordings were made in the presence of 50 μM picrotoxin to block GABA~A~ receptors (Tocris) and the NMDA receptor antagonist L-689,560 (trans-2-carboxy-5,7-dichloro-4-phenylaminocarbonylamino-1,2,3,4-tetrahydroquinoline; 5 μM; Tocris). Field EPSPs were evoked at 0.1 Hz (200 μs stimulus), with a 20-min baseline recorded at a stimulus intensity that gave 40% of the maximal response. To induce mGluR-LTD, 50 or 100 μM of (RS)-3,5-DHPG (3,5-dihydroxyphenylglycine, Tocris) was applied for 10 min and then washed off for at least one hour as previously described ([@bib7]). Recordings of fEPSPs were made using a differential model 3000 amplifier (AM systems, WA USA) with signals filtered at 3 kHz and digitized online (10 kHz) with a Micro CED (Mark 2) interface controlled by Spike software (Vs 7.08), Cambridge Electronic Design, Cambridge UK). Field EPSPs were analyzed using Spike software and graphs prepared using Origin (Microcal), with the slope of fEPSPs measured for a 1 ms linear region following the fiber volley.

### Statistical Analysis {#sec4.3.12}

Statistical analyses applied were the post hoc Student's t test or repeated-measures ANOVA with pairwise multiple comparisons. Behavioral data were analyzed using two-way or repeated-measures Analysis of Variance (ANOVA). Fisher's protected least-significant difference (PLSD) tests were used for comparing group means only when a significant F value was determined. For all comparisons, significance was set at p ≤ 0.05. Data presented in figures and tables are means (±SEM).
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